Blog - Page 353 of 5676 - QualityStocks

ThursdayMar 06, 2025 8:30 am

QualityStocksNewsBreaks – ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Reports 90.9% Gold Recovery Using Non-Cyanide CLEVR Process at Montauban

ESGold (CSE: ESAU) (OTCQB: ESAUF) has announced metallurgical test results from its collaboration with Dundee Sustainable Technologies, confirming 90.9% gold recovery using the non-cyanide CLEVR Process™ on legacy tailings from the Montauban Project. Silver grades reached 760 g/t, and gold grades improved from 3.69 g/t to 6.01 g/t following oxidation. The process also reduced sulphide content from 29% to 0.48% and achieved full gold leaching in one hour. ESGold will now focus on optimizing the process for throughput and silver recovery as part of its clean mining strategy. To view the full press release, visit https://ibn.fm/MyHco About ESGold Corp. ESGold…

WednesdayMar 05, 2025 3:28 pm

QualityStocksNewsBreaks – Adageis: Shaping the Future of Healthcare with AI-Powered Solutions

Adageis offers AI-driven solutions that help providers transition to and optimize value-based care models. “Healthcare is undergoing a major transformation as more organizations shift from fee-for-service to value-based care. Under value-based care models, providers are reimbursed based on patient outcomes rather than the volume of services rendered. This approach incentivizes proactive care, chronic disease management and overall cost efficiency,” a recent article explains. “Adageis, a forward-thinking healthcare technology company reshaping patient care through flexible AI-centric software solutions, is helping providers streamline their transition to value-based models. Through its ProActive Care Platform, Adageis enables healthcare organizations to optimize patient care while maximizing…

WednesdayMar 05, 2025 2:39 pm

QualityStocksNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Stands at the Forefront of Integrating New Oncology Therapies

Calidi Biotherapeutics (NYSE American: CLDI) is leveraging innovative platforms in a commitment to transform cancer treatment using advanced biotechnology. “The company is pioneering therapies that combine stem cells with antitumor viruses to create powerful cancer treatments. Antitumor viruses or virotherapies selectively infect and destroy cancer cells while sparing normal cells and, when paired with stem cells, their therapeutic potential is significantly amplified,” reads a recent article. “Calidi’s pipeline includes the proprietary SuperNova (‘SNV’) platform, which utilizes allogeneic adipose-derived mesenchymal stem cells (‘AD-MSCs’) as carriers for antitumor virotherapy. This approach has shown promise in preclinical studies and safety studies, with potential applications…

WednesdayMar 05, 2025 11:30 am

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Pioneers Systemic Virotherapy with RTNova Platform

Calidi's RTNova platform leverages engineered enveloped vaccinia viruses designed for systemic delivery. Calidi's groundbreaking virotherapy holds “immense promise in revolutionizing the treatment landscape for cancer patients with advanced solid tumors,” says CEO. Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage biotechnology company at the forefront of developing innovative immunotherapies for cancer treatment. Most recently, the company has captured the spotlight for the development of its proprietary systemic platform, RTNova (https://ibn.fm/Z4pM3). The platform represents a significant advancement in systemic virotherapy, particularly in the utilization of enveloped virotherapies to target metastatic tumors across the body. Antitumor virotherapy employs viruses that selectively infect…

WednesdayMar 05, 2025 10:45 am

Clene Inc. (NASDAQ: CLNN) to Highlight Latest Achievements, Next Steps for CNM-Au8(R), at Q1 Virtual Investor Summit on March 11

The Q1 Virtual Investor Summit will focus on microcap companies that are undervalued, and aim to create connections between leading investors and microcap companies Clene’s presentation will be given by CEO Rob Etherington and CFO Morgan Brown Clene’s participation in the event comes as the company is moving closer to submitting a New Drug Application to the FDA to secure potential accelerated approval for CNM-Au8® for ALS The company recently partnered with German-based APST Research GmbH to analyze neurofilament light chain (“NfL”) data for evaluating CNM-Au8 efficacy in ALS patients. Clene Inc. (NASDAQ: CLNN) and its wholly owned subsidiary, Clene…

WednesdayMar 05, 2025 10:00 am

Advancing KOL and MSL Excellence: Key Insights from the 6th Annual Summit

The 6th KOL & MSL Expertise Summit, held on February 26-27, 2025, in Philadelphia, convened professionals from the pharmaceutical and biotechnology sectors to delve into the evolving dynamics between Key Opinion Leaders (“KOLs”) and Medical Science Liaisons (“MSLs”). The summit offered a platform for in-depth discussions on enhancing collaboration, refining insight programs, and aligning strategies with business objectives. Key Sessions and Speakers: Build Core Competencies in Business Acumen and Strategic Thinking: Adeola Davis, Director of Learning & Development, Medical Affairs, Acadia Pharma, discussed strategies to enhance MSLs’ understanding of business operations, fostering a collaborative mindset aligned with corporate objectives. Elevate…

WednesdayMar 05, 2025 9:40 am

QualityStocksNewsBreaks – Massimo Group (NASDAQ: MAMO) Strengthens Retail Partnerships at Industry Events

Massimo Group (NASDAQ: MAMO), a manufacturer of powersports vehicles, is deepening relationships with key retail partners through participation in major industry events. The company recently attended the Rural King Vendor Summit in Mattoon, Illinois, and is currently engaging with Tractor Supply Company & PetSense representatives at their ASM and Partner Trade Show in Nashville, Tennessee. These events allow Massimo to collaborate with store managers, buyers, and executives to align its UTVs, ATVs, and outdoor equipment with customer needs. The company aims to enhance its market presence by leveraging direct feedback from retail partners and expanding its strategic partnerships. To view the…

WednesdayMar 05, 2025 8:30 am

QualityStocksNewsBreaks – Capstone Holding Corp. (NASDAQ: CAPS) Prices $5 Million Follow-on Offering at $4 Per Share

Capstone Holding Corp. (NASDAQ: CAPS), a building products distribution company, priced its follow-on public offering of 1.25 million common shares at $4.00 each, aiming to raise $5 million in gross proceeds before expenses. The shares are expected to begin trading on the Nasdaq Capital Market on March 6 under the ticker "CAPS." The company also granted underwriters a 45-day option to purchase up to 187,500 additional shares. The offering is set to close on or about March 7, pending customary conditions. To view the full press release, visit https://ibn.fm/tD5PA About Capstone Holding Corp. Capstone Holding Corp. is a building products…

TuesdayMar 04, 2025 1:35 pm

QualityStocksNewsBreaks – Match Group Inc. (NASDAQ: MTCH) Promotes Hesam Hosseini to COO; President Gary Swidler to Step Down

Match Group (NASDAQ: MTCH), has announced significant executive changes, promoting Hesam Hosseini to Chief Operating Officer effective April 1, 2025. Hosseini, who has been with the company since 2008, currently serves as CEO of Evergreen & Emerging Brands within Match Group. In his new role, he will focus on driving growth and execution across the company's global portfolio. Concurrently, Gary Swidler will step down as President on April 1 and continue as an advisor until July 4, 2025, marking the end of his decade-long tenure during which he played a pivotal role in taking the company public and driving strategic…

TuesdayMar 04, 2025 1:25 pm

QualityStocksNewsBreaks – Tesla Inc. (NASDAQ: TSLA) Price Target Cut 22% by Bank of America on Tariff Risks

Tesla (NASDAQ: TSLA) saw its price target slashed by 22% at Bank of America, with analysts lowering their outlook from $490 to $380. The downgrade reflects growing concerns over potential tariff risks that could impact Tesla’s supply chain and sales, particularly as trade tensions between the U.S. and key international markets escalate. Analysts cited uncertainty surrounding electric vehicle demand and higher production costs as additional headwinds for the automaker. As of the latest trading session, Tesla shares traded at $268.47, down 5.7% on the day. The stock has fluctuated between an intraday high of $285.86 and a low of $262.00.…

Site Search

Company Search